Home
    Disclaimer
    4-Fluorobutyrfentanyl molecular structure

    4-Fluorobutyrfentanyl Stats & Data

    Pfbf 4-fbf parafluorobutyrfentanyl
    Chemical Class Opioid
    Psychoactive Class Depressant

    History & Culture

    4-Fluorobutyrfentanyl emerged as a designer drug sold online as part of the broader wave of synthetic opioid analogs appearing in illicit markets. Structurally, it is an analog of butyrfentanyl and is closely related to 4-fluorofentanyl, representing one of numerous modifications to the fentanyl scaffold explored by clandestine chemists. The compound is reportedly rare, and there is limited documentation regarding its origins, synthesis history, or the specific circumstances of its introduction to the recreational drug market. Like many novel synthetic opioids, it appears to have been developed and distributed primarily through online vendors catering to the research chemical market.

    Effect Profile

    Curated + 2 Reports
    Opioid 6.3

    Strong euphoria with moderate itching/nausea, mild pain relief, low sedation

    Euphoria / Warmth×3
    10
    Analgesia×2
    4
    Sedation / Relaxation×1
    3
    Itching / Nausea×1
    7

    Tolerance & Pharmacokinetics

    drugs.wiki

    Tolerance Decay

    Full tolerance 1d Half tolerance 21d Baseline ~35d

    Experience Report Analysis

    Erowid
    2 Reports
    2015–2015 Date Range
    2 With Age Data

    Demographics

    Gender Distribution

    Age Distribution

    Reports Over Time

    Form / Preparation

    Most common forms and preparations reported

    Legal Status

    Country Status Notes
    China Controlled substance Became a controlled substance in October 2015 as part of China's efforts to restrict synthetic opioid production and distribution.
    Sweden Hazardous substance (proposed) Sweden's public health agency recommended classification as a hazardous substance on August 18, 2014. This designation restricts sale and possession under Swedish drug control legislation.
    United States Schedule I Classified as a Schedule I controlled substance under federal law since February 1, 2018. This designation indicates high abuse potential with no accepted medical use.
    ← Back to 4-Fluorobutyrfentanyl